Cited by 1,275Liver Disease Diagnosis and TreatmentUltrasound Imaging and ElastographyUltrasound in Clinical Applications

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Open access

Karlas, Thomas, Petroff, David, Sasso, Magali, Fan, Jian-Gao, Mi, Yu-Qiang, de Lédinghen, Victor, Kumar, Manoj, Lupsor-Platon, Monica, Han, Kwang-Hyub, Cardoso, Ana C., Ferraioli, Giovanna, Chan, Wah-Kheong, Wong, Vincent Wai-Sun, Myers, Robert P., Chayama, Kazuaki, Friedrich-Rust, Mireen, Beaugrand, Michel, Shen, Feng, Hiriart, Jean-Baptiste, Sarin, Shiv K., Badea, Radu, Jung, Kyu Sik, Marcellin, Patrick, Filice, Carlo, Mahadeva, Sanjiv, Wong, Grace Lai-Hung, Crotty, Pam, Masaki, Keiichi, Bojunga, Joerg, Bedossa, Pierre, Keim, Volker, Wiegand, Johannes·2017·Journal of Hepatology

DOI 10.1016/j.jhep.2016.12.022

Open this paper in CoChat — free account

Abstract

Background & aims The prevalence of fatty liver underscores the need for non-invasive characterization of steatosis, such as the ultrasound based controlled attenuation parameter (CAP). Despite good diagnostic accuracy, clinical use of CAP is limited due to uncertainty regarding optimal cut-offs and the influence of covariates. We therefore conducted an individual patient data meta-analysis.Methods A review of the literature identified studies containing histology verified CAP data (M probe, vibration controlled transient elastography with FibroScan®) for grading of steatosis (S0-S3). Receiver operating characteristic analysis after correcting for center effects was used as well as mixed models to test the impact of covariates on CAP. The primary outcome was establishing CAP cut-offs for distinguishing steatosis grades.Results Data from 19/21 eligible papers were provided, comprising 3830/3968 (97%) of patients. Considering data overlap and exclusion criteria, 2735 patients were included in the final analysis (37% hepatitis B, 36% hepatitis C, 20% NAFLD/NASH, 7% other). Steatosis distribution was 51%/27%/16%/6% for S0/S1/S2/S3. CAP values in dB/m (95% CI) were influenced by several covariates with an estimated shift of 10 (4.5-17) for NAFLD/NASH patients, 10 (3.5-16) for diabetics and 4.4 (3.8-5.0) per BMI unit. Areas under the curves were 0.823 (0.809-0.837) and 0.865 (0.850-0.880) respectively. Optimal cut-offs were 248 (237-261) and 268 (257-284) for those above S0 and S1 respectively.Conclusions CAP provides a standardized non-invasive measure of hepatic steatosis. Prevalence, etiology, diabetes, and BMI deserve consideration when interpreting CAP. Longitudinal data are needed to demonstrate how CAP relates to clinical outcomes.Lay summary There is an increase in fatty liver for patients with chronic liver disease, linked to the epidemic of the obesity. Invasive liver biopsies are considered the best means of diagnosing fatty liver. The ultrasound based controlled attenuation parameter (CAP) can be used instead, but factors such as the underlying disease, BMI and diabetes must be taken into account. Registration: Prospero CRD42015027238.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2016.12.022

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statisctics and computing/Statistics and computing · doi:10.1007/978-0-387-21706-2 · Cited by 25,941
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Fitting Linear Mixed-Effects Models Using lme4Preprint
Bates, D. M., Maechler, M., Bolker, B. M., & Walker, S. (2014) · arXiv (Cornell University) · doi:10.3929/ethz-b-000105397 · Cited by 9,435
Histological grading and staging of chronic hepatitis.
Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,854
Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C
Bédossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,189
AASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2015) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,002

Flagged first, then by citations

Show all 65 references

1 of the 65 references couldn’t be matched to a known paper.

Sorted by citations

Items 701–800 of 1,000

Characterization of hepatic steatosis using controlled attenuation parameter and MRI‐derived proton density fat fraction in living donor liver transplantation
Zhuang, R. H., Weinstock, A. K., Ganesh, S., Behari, J., Malik, S. M., Bataller, R. A., Furlan, A., Hughes, C. B., Humar, A., & Duarte‐Rojo, A. (2022) · Clinical Transplantation · doi:10.1111/ctr.14786 · Cited by 6
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
Salgado‐Álvarez, G. A., Gálvez, S. M. P., Mora, U. G., Cano-Contreras, A. D., Durán-Rosas, C., Priego-Parra, B. A., Triana‐Romero, A., Amieva‐Balmori, M., Dietlen, F. B. R., Vázquez, S., et al. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i8.1633 · Cited by 6
Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
Trifan, A. V., Cuciureanu, T., Năstasă, R., Stratina, E., Zenovia, S., Muzica, C. M., Huiban, L., Sîngeap, A.-M., Chiriac, S. A., Sfarti, C. V., et al. (2023) · Life · doi:10.3390/life13020534 · Cited by 6
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists
Gracen, L., Muthukumara, W., Aikebuse, M., Russell, A. W., O’Beirne, J. P., Irvine, K. M., Williams, S., Puri, G., Valery, P. C., Hayward, K. L., et al. (2023) · Annals of Hepatology · doi:10.1016/j.aohep.2023.101142 · Cited by 6
Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression
Volkert, I., Fromme, M., Schneider, C. V., Candels, L. S., Lindhauer, C., Su, H., Thorhauge, K. H., Pons, M., Mohamed, M., Schneider, K. M., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000574 · Cited by 6
The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis
Hu, D., Wang, P., Wang, X., Hu, X., Huang, D., Yan, W., Xi, D., Han, M., Ning, Q., & Wang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28653 · Cited by 6
Accelerometer-based sedentary time and physical activity with MASLD and liver cirrhosis in 2684 British adolescents
Agbaje, A. O. (2024) · npj gut and liver. · doi:10.1038/s44355-024-00002-y · Cited by 6
Non-invasive Assessment of Liver Steatosis and Fibrosis Using Transient Elastography and Controlled Attenuation Parameter in type 2 Diabetes Patients
Sima, L. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.394 · Cited by 6
Efficacy of Elbasvir/Grazoprevir Therapy in HCV Genotype-1 with or without HIV Infection: Role of HCV Core Antigen Monitoring and Improvement of Liver Stiffness and Steatosis
Chayanupatkul, M., Chittmittraprap, S., Pratedrat, P., Chuaypen, N., Avihingsanon, A., & Tangkijvanich, P. (2019) · Antiviral Therapy · doi:10.3851/imp3370 · Cited by 6
The Prevalence and Determinants of Hepatic Steatosis Assessed by Controlled Attenuation Parameter in Thai Chronic Hepatitis C Patients
Sirinawasatien, A., & Techasirioangkun, T. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/8814135 · Cited by 6
Correlation Between Sex Hormones and Non-alcoholic Fatty Liver Disease Before and After Laparoscopic Sleeve Gastrectomy
Dilimulati, D., Cai, M., Lin, Z., Zhang, Y., Du, L., Zhou, D., Zhu, J., Su, L., Wang, Y., Zhang, M., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05663-9 · Cited by 6
Comparison of non-invasive fibrosis scores to predict increased liver stiffness in the general population with unknown liver disease: Searching for the primary physician's best friend
Coste, P., Llop, E., Perelló, C., Hernández, M., López, M., Abad, J., Ferré, C., Lázaro‐Martínez, J. L., Fernández, N., & Calleja, J. L. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.03.013 · Cited by 6
Alterations in circulating lipidomic profile in patients with type 2 diabetes with or without non-alcoholic fatty liver disease
Alfadda, A. A., Almaghamsi, A. M., Sherbeeni, S. M., Alqutub, A. N., Aldosary, A. S., Isnani, A. C., Al‐Daghri, N. M., Taylor-Robinson, S. D., & Gul, R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1030661 · Cited by 6
Pathological findings of liver steatosis that is difficult to evaluate with ultrasound
Kondo, R., Kusano, H., Mihara, Y., Kage, M., Akiba, J., & Yano, H. (2021) · Journal of Medical Ultrasonics · doi:10.1007/s10396-021-01126-x · Cited by 6
Controlled Attenuation Parameter in Nonalcoholic Fatty Liver Disease: The Thresholds Do Matter
Kozłowska‐Petriczko, K., Wunsch, E., & Milkiewicz, P. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.08.055 · Cited by 6
Liver Ultrasound Attenuation: An Ultrasound Attenuation Index for Liver Steatosis Assessment.
Gatos, I., Drazinos, P., Yarmenitis, S., Theotokas, I., Koskinas, J. S., Koullias, E., Mitranou, A., Manesis, E. K., & Zoumpoulis, P. S. (2022) · PubMed · doi:10.1097/ruq.0000000000000605 · Cited by 5
Accuracy of controlled attenuation parameter for liver steatosis in patients at risk for metabolic dysfunction-associated steatotic liver disease using magnetic resonance imaging: a systematic review and meta-analysis
Malandris, K. (2024) · Annals of Gastroenterology · doi:10.20524/aog.2024.0910 · Cited by 6
Association of blood manganese and selenium levels with hepatic steatosis among adolescents: a nationwide cross-sectional analysis
You, B., & Chen, Z. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1522219 · Cited by 5
Waist-to-Height Ratio Enhances Predictive Accuracy for Severe Hepatic Steatosis and Advanced Fibrosis: A National Cohort Study
Niezen, S., Mendes, T. B., & Tapper, E. B. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.05.003 · Cited by 5
Association of chronic kidney disease and type 2 diabetes mellitus with metabolic dysfunction-associated steatotic liver disease and liver fibrosis assessed by transient elastography: a cross-sectional study based on NHANES 2017–2020
Xu, T., & Zhu, W. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112418 · Cited by 7
Deep learning for non-invasive detection of steatosis and fibrosis in MASLD: a multicenter study with a new fibroscan-labelled ultrasound dataset
Bose, K., Mudgil, P., Gupta, P. C., Ralmilay, S., Dutta, N., Gulati, A., Kalra, N., Premkumar, M., Taneja, S., Verma, N., et al. (2025) · Abdominal Radiology · doi:10.1007/s00261-025-05309-9 · Cited by 5
Mediterranean and low-fat diets are equally effective in MASLD resolution at 12 weeks regardless of PNPLA3 genotype: A randomized controlled trial
Us, G. D., Innocenti, F., Koc, Ö. M., Alagoz, A. E., Yumuk, V., Gungor, Z. B., & Koek, G. H. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000856 · Cited by 7
Non‐invasive diagnosis of metabolic dysfunction‐associated steatotic liver disease: Current status, challenges, and future directions
Ma, Y., Zhang, C., Tian, M., Hu, J., Wang, M., & Liu, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70326 · Cited by 5
Assessment of hepatic steatosis and liver stiffness using transient elastography in late pregnancy: a cross-sectional study
Manna, L. B., Chatzakis, C., Ovadia, C., Williamson, C., & Nicolaides, K. H. (2025) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/j.lanogw.2025.100038 · Cited by 5
Epidemiology and diagnostic of MASLD in Latin America: a yet to be met challenge
Olaez-Ramos, C. E., Mojica-Zamudio, K. L., Sandoval-Rodriguez, A. S., & Armendáriz‐Borunda, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1700072 · Cited by 7
MG53 mediates skeletal muscle-liver cross-talk and enhances alcohol metabolism in alcoholic liver disease
Shu, T., Zeng, X., Wang, J., Jiang, H., Wang, Y., Zhang, M., Jiang, L., He, B., Yang, L., Liu, N., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69132-6 · Cited by 6
A new visual quantitative assessment of ultrasound attenuation parameters for the mild liver steatosis
Ren, X., Wang, J., Xia, S., Zhan, W., Li, R., Chen, Z., & Tian, J. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-989 · Cited by 5
Advanced liver fibrosis predicts heart failure and hospitalizations in people with type 2 diabetes: A prospective cohort study from Hong Kong Diabetes Register
Kong, A. P. S., Lau, E. S. H., Chun Kwan, O., Luk, A. O. Y., Yip, T. C., Chow, E., Kwok, R., Lee, H. W., Wong, G. L., Ronald, C. W., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110825 · Cited by 6
Self-citation
Associations of Urinary Nickel with NAFLD and Liver Fibrosis in the USA: A Nationwide Cross‑Sectional Study
Zhang, K., Yang, C., Zhao, X. Q., Wang, Y., Gu, Z., Yang, R., Ding, H., Li, S., Qin, J., & Chu, X. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04151-2 · Cited by 5
Update on Imaging-based Noninvasive Methods for Assessing Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
Kang, C., Wang, T.-E., Liu, C., Chen, M., Wang, H., Chang, C., & Chang, C.-W. (2024) · Journal of Medical Ultrasound · doi:10.4103/jmu.jmu_88_23 · Cited by 5
The association between stress hyperglycemia ratio and nonalcoholic fatty liver disease among U.S. adults: A population-based study
Xi, W., Liao, W., Li, J., Yang, Y., Guo, T., Jiang, Q., & Yang, A. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.10.018 · Cited by 5
Protocol for a Longitudinal Cohort Study to Understand Characteristics and Risk Factors Underlying Vibration-Controlled Transient Elastography-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease Children
Yang, F., Hu, M., Zhang, H., Zheng, X., Chen, L., Zhu, L., & Zhang, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s492809 · Cited by 5
Liver Disease Complicating Familial Mediterranean Fever: A Study on 66 Patients Out of 533 Adult From the JIR Cohort
Delplanque, M., Amiot, X., Wendum, D., Rodrigues, F., Aknouche, Z., Bourguiba, R., Terris, B., Duvoux, C., Bédossa, P., Lebrec, D., et al. (2025) · Liver International · doi:10.1111/liv.16232 · Cited by 5
Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017–2020
Zou, Y., Dai, Y., Li, Z., Lin, B., Chen, H., Zhuang, Z., Li, W., Yang, Q., & Dai, D. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03915-x · Cited by 5
Aggregate index of systemic inflammation tied to increased fatty liver disease risk: insights from NHANES data
Zhang, M., Yuan, Y., Wang, C., Huang, Y., Fan, M., Li, X., & Qin, Z. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03998-6 · Cited by 5
Association between the TyG index and MAFLD and its subtypes: a population-based cross-sectional study
Liu, C., Li, C., Fu, J., Bai, L., Wang, M., Song, P., & Zheng, M. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04195-1 · Cited by 5
Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis
Jin, H., Jiao, M., Yu, C., Ren, T., Chen, Q., Dai, Z., Xie, E., Jiang, L., & Li, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-03229-4 · Cited by 5
Liver Steatosis (CAP) as Modifier of Liver Stiffness
Karlas, T., & Mueller, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-40542-7_39 · Cited by 5
Self-citation
Hepatic steatosis as measured by the computed attenuation parameter predicts fibrosis in long-term methotrexate use
Tomaszewski, M., Dahiya, M., Mohajerani, S. A., Punja, H., Ko, H. H., Sun, M., & Ramji, A. S. (2021) · Canadian Liver Journal · doi:10.3138/canlivj-2020-0040 · Cited by 5
Non-Invasive Assessment of Liver Fibrosis and Steatosis in End-Stage Renal Disease Patients Undergoing Renal Transplant Evaluation
Syed, T., Chadha, N., Kumar, D., Gupta, G., & Sterling, R. K. (2021) · Gastroenterology Research · doi:10.14740/gr1445 · Cited by 5
The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States
Wijarnpreecha, K. (2022) · Annals of Gastroenterology · doi:10.20524/aog.2022.0687 · Cited by 5
Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection
Mak, L., Wong, D. K.-H., Cheung, K. S., Hui, R. W., Liu, F., Fung, J., Seto, W., & Yuen, M. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07429-4 · Cited by 5
Magnetic resonance imaging metrics and the predictability of adverse outcomes in on‐treatment Asian chronic hepatitis B
Hui, R. W., Chiu, K. W.-H., Mak, L., Chang, H., Cheung, K. S., Fung, J., Yuen, M., & Seto, W. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15846 · Cited by 5
The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound
Ding, Y., Jiang, L., Wang, Q., Zhao, W., Zhou, X., Lü, J., Tian, T., Yu, C., Xu, X. P., Guo, W., et al. (2022) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2022.101951 · Cited by 5
Agreement and accuracy of shear-wave techniques (point shear-wave elastography and 2D-shear-wave elastography) using transient elastography as reference
Fernandes, F. F., Piedade, J., de Freitas, G. R. P., Area, P., dos Santos, R. R., Grinsztejn, B. G. J., Veloso, V. G., Pereira, G., & Perazzo, H. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002400 · Cited by 5
Lead exposure was associated with liver fibrosis in subjects without known chronic liver disease: An analysis of NHANES 2017–2020
Zhang, Z., Li, Z., Lin, H., Zeng, Z., Huang, J., & Li, D. (2022) · Frontiers in Environmental Science · doi:10.3389/fenvs.2022.995795 · Cited by 5
Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR
Chadha, N., Turner, A., & Sterling, R. K. (2022) · Journal of Viral Hepatitis · doi:10.1111/jvh.13763 · Cited by 5
Communicating PNPLA3 genetic risk status for NAFLD among Mexican-origin men
Villavicencio, E. A., Maldonado, A., Crocker, R. M., Guan, Y., Stallman, C., & Garcia, D. O. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1090101 · Cited by 5
Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus
Liu, J., Qi, W., Wang, S., Zhang, Y., Wang, X., Sun, D., Xu, Y., Shi, J., Duan, H., Zhang, Q., et al. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01858-4 · Cited by 5
Association Between Fatty Liver Index, Controlled Attenuation Parameter, and Metabolic Syndrome Stages: A Community-Based Study
Chong, L. W., Bintoro, B. S., Tsai, M., Lin, Y., & Bai, C. (2023) · Medical Science Monitor · doi:10.12659/msm.940691 · Cited by 5
Glucocorticoid Replacement for Adrenal Insufficiency and the Development of Non-Alcoholic Fatty Liver Disease
Meyer, G., Gruendl, M., Chifu, I. O., Hahner, S., Werner, J., Weiß, J., Kienitz, T., Quinkler, M. O., Badenhoop, K. W. J., Herrmann, E. M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196392 · Cited by 5
Self-citation
Non-metabolic causes of steatotic liver disease
Nasr, P., Jönsson, C., Ekstedt, M., & Kechagias, S. (2023) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.20 · Cited by 5
Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria
Liu, Y., Chai, S., & Zhang, X.-M. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13501 · Cited by 7
Reference values and associated factors of controlled attenuation parameter and liver stiffness in adults: A cross-sectional study
Ramírez‐Vélez, R., Izquierdo, M., García‐Hermoso, A., & Correa‐Rodríguez, M. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.04.004 · Cited by 5
Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD
Moragrega, Á. B., Busca, C., Apostolova, N., Olveira, A., Martín‐Carbonero, L., Valencia, E., Moreno, V., Bernardino, J. I., Abadía, M., González‐García, J., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071454 · Cited by 5
Relevance of combined influence of nutritional and inflammatory status on non‐alcoholic fatty liver disease and advanced fibrosis: A mediation analysis of lipid biomarkers
Pan, L., Wang, L., Ma, H., & Ding, F. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16760 · Cited by 5
Guided-VCTE: An Enhanced FibroScan Examination With Improved Guidance and Applicability
Bastard, C., Audière, S., Foucquier, J., Lorée, H., Miette, V., Bronowicki, J., Stern, C., Caussy, C., & Sandrin, L. (2025) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.12.007 · Cited by 5
Controlled Attenuation Parameter in Healthy Individuals Aged 8–70 Years
Mjelle, A. B., Mulabecirovic, A., Olafsdottir, E. J., Gilja, O. H., Havre, R. F., & Vesterhus, M. N. (2021) · Ultrasound International Open · doi:10.1055/a-1461-4714 · Cited by 5
Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States’ adolescent population
Atsawarungruangkit, A., Elfanagely, Y., Pan, J., Anderson, K., Scharfen, J., & Promrat, K. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i7.790 · Cited by 5
Vibration‐controlled transient elastography for noninvasive evaluation of liver steatosis
Pearson, A., Dujardin, P., d’Altéroche, L., Patat, F., Scotto, B., Dujardin, F., Bastard, C., Miette, V., Sandrin, L., & Réméniéras, J.-P. (2022) · Medical Physics · doi:10.1002/mp.15484 · Cited by 5
Left ventricular strain predicts subclinical atherosclerosis in nonadvanced nonalcoholic fatty liver disease patients
Sonaglioni, A., Cerini, F., Nicolosi, G. L., Lombardo, M., Rumi, M. G., & Viganò, M. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002375 · Cited by 5
Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests
Guillaud, O., Dumortier, J., Couchonnal‐Bedoya, E., & Ruiz, M. (2023) · Diagnostics · doi:10.3390/diagnostics13020256 · Cited by 5
A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis
Björkström, K., Stal, P. I., Holmer, M., Bengtsson, B., Staaf, A., Hoffstedt, J., & Hagström, H. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001882 · Cited by 5
Imaging methods in the assessment of nonalcoholic fatty liver disease
Parente, D. B. (2020) · Radiologia Brasileira · doi:10.1590/0100-3984.2020.53.2e3 · Cited by 5
Parental obesity and risk of metabolic dysfunction associated steatotic liver disease in adult offspring: UK birth cohort study
Tica, S., Luo, C., Ren, D., Zong, X., Thompson, M. D., Stoll, J. M., DeBosch, B. J., Tarr, P. I., & Cao, Y. (2026) · Gut · doi:10.1136/gutjnl-2025-336165 · Cited by 4
Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity
Peng, T., Yi, X., Lin, Y., Dong, X., Zhang, P., Zhi-Hui, Q. I. A. O., & Li, L. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2023-0566 · Cited by 4
Diagnostic performance of two-dimensional shear wave elastography and attenuation imaging for fibrosis and steatosis assessment in chronic liver disease
Kobayashi, T., Nakatsuka, T., Sato, M., Soroida, Y., Hikita, H., Gotoh, H., Iwai, T., Tateishi, R., Kurano, M., & Fujishiro, M. (2024) · Journal of Medical Ultrasonics · doi:10.1007/s10396-024-01473-5 · Cited by 4
LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease
Leow, Y., Chan, W. L., Lai, L. L., Mustapha, N. R. N., Mahadeva, S., Quiambao, R., Munteanu, M., & Chan, W. K. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16675 · Cited by 4
Self-citation
The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
Sasada, T., Iino, C., Sato, S., Tateda, T., Igarashi, G., Yoshida, K., Sawada, K., Mikami, T., Nakaji, S., Sakuraba, H., et al. (2024) · Nutrients · doi:10.3390/nu16172877 · Cited by 4
Ultraportable Quantitative Ultrasound for Hepatic Steatosis Assessment
Hériard-Dubreuil, B., Besson, A., Mamou, J., Gay, J., Foucher, J., de Lédinghen, V., & Cohen‐Bacrie, C. (2024) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.08.008 · Cited by 4
Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and its association with arterial stiffness in adolescents: Results from the EVA4YOU study
Nairz, J., Messner, A., Zollner-Kiechl, S., Winder, B., Hochmayr, C., Granna, J., Egger, A., Griesmacher, A., Geiger, R., Knoflach, M., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314585 · Cited by 4
Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV
Macı́as, J., Frías, M., Pineda, J. A., Corona‐Mata, D., Corma‐Gómez, A., Rivero‐Juárez, A., Santos, M. L., Deltoro, M. G., Rivero, A., Ricart-Olmos, C., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18413 · Cited by 4
Use of Fibroscan Liver Elastography in the Rapid Diagnosis and Monitoring of MASLD Treatment
Rajewski, P., Cieściński, J., & Rajewski, P. (2024) · Annals of Case Reports · doi:10.29011/2574-7754.102129 · Cited by 4
Coexisting steatotic liver disease is not associated with long-term liver-related events in patients with chronic hepatitis B
Uman, N., Kaewdech, A., Sripongpun, P., Chamroonkul, N., & Piratvisuth, T. (2025) · Gastroenterology report · doi:10.1093/gastro/goaf013 · Cited by 4
Enhancing Liver Steatosis Classification: H-Scan Analysis of Handheld Ultrasound Data
Gabriel, T., Chaghaneh, O., Kober, J., Trittler, T., Dorausch, E. M. G., Kühnöl, C., Schäfer, J., Nauber, R., Koop, P., Schneider, C. V., et al. (2025) · IEEE Open Journal of Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/ojuffc.2025.3566928 · Cited by 4
Serum Tsukushi level is negatively associated with cholesterol efflux capacity in metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
Lam, S., Lui, D. T. W., Fong, C. H.-Y., Wong, Y., Shiu, S. W. M., Lam, K. S. L., Mak, L., Yuen, M., Lee, C., & Tan, K. C. B. (2025) · Scientific Reports · doi:10.1038/s41598-025-06431-w · Cited by 4
Prevalence and Risk Factors of Liver Fibrosis Among People With HIV and Metabolic Dysfunction–Associated Steatotic Liver Disease
Xu, W., Liu, D., Zhang, R., Chen, J., & Shen, Y. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf369 · Cited by 4
Defining optimal fatty liver index thresholds for MASLD and MetALD using controlled attenuation parameter as reference
Fujii, H., Uchida‐Kobayashi, S., Kanamori, A., Nadatani, Y., Kawamura, E., Kimura, T., Fukumoto, S., & Watanabe, T. (2025) · Journal of Gastroenterology · doi:10.1007/s00535-025-02287-z · Cited by 4
Development and clinical validation of a novel protein biomarkers-based algorithm for risk prediction and diagnosis of advanced liver fibrosis: a multi-centre study
Cheung, C. Y. Y., Wan, P., Wan, H., Xu, C., Jia, X., Fong, C. H.-Y., Lui, D. T. W., Song, E., Chen, X., Chow, W.-S., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.033 · Cited by 4
Pathogenesis, diagnosis and management of chronic hepatitis B related liver fibrosis
Kösekli, M. A., & Aktaş, G. (2025) · Minerva Gastroenterology · doi:10.23736/s2724-5985.25.03862-8 · Cited by 4
A comparative study between ultrasound-guided-attenuation-parameter (UGAP), controlled attenuation parameter (CAP), and proton density fat fraction (PDFF) for assessment of hepatic steatosis
Byenfeldt, M., Grönlund, C., Nasr, P., Lindam, A. P., Ekstedt, M., Lundberg, P., & Kihlberg, J. (2025) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2025.2594790 · Cited by 4
Metabolic dysfunction-associated fatty liver disease and risk of hypertension in young adults: A cross-sectional study mediated by inflammatory markers
Zheng, J., & Lu, C. (2025) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2025.2597852 · Cited by 4
Sex-Specific Cardiometabolic Profiles and Severity of Liver Fibrosis
Albhaisi, S. A. M., Kim, S. S., Terrault, N. A., & Dodge, J. L. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.0863 · Cited by 6
Metabolic dysfunction‐associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia
Wong, W., Chan, W., Ganapathy, S. S., & Lim, S. K. (2022) · Seminars in Dialysis · doi:10.1111/sdi.13117 · Cited by 4
Self-citation
Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis
Donath, H., Wölke, S., Knop, V., Heß, U., Duecker, R. P., Trischler, J., Poynard, T., Schubert, R., & Zielen, S. (2023) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2023/2877350 · Cited by 4
Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography
Suresh, M. G., Gogtay, M., Singh, Y., Yadukumar, L., Mishra, A. K., & Abraham, G. M. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i34.8126 · Cited by 4
Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD
Hu, D., Wang, P., Wang, X., Hu, X., Huang, D., Yan, W., Xi, D., Han, M., Ning, Q., & Wang, H. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.12.001 · Cited by 4
The Effect of Steatosis on Shear-Wave Velocity and Viscoelastic Properties Related to Liver Fibrosis Progression in Rat Models
Tamura, K., Ito, K., Kishimoto, R., Yoshida, K., Kishimoto, T., Obata, T., & Yamaguchi, T. (2024) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.01.002 · Cited by 4
Multiparametric Ultrasound for Chronic Liver Disease
Barr, R. G. (2024) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2024.07.003 · Cited by 4
Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial
Perva, I. T., Simina, I.-E., Bende, R., Motofelea, A. C., Chiriță-Emandi, A., Andreescu, N. I., Sima, A. C., Vlad, A., Sporea, I., Zimbru, C. G., et al. (2024) · Medicina · doi:10.3390/medicina60081366 · Cited by 4
Association of cardiovascular disease risk with liver steatosis and fibrosis in people with HIV in low- and middle-income countries
Kuniholm, M. H., Murenzi, G., Shumbusho, F., Brazier, E., Plaisy, M. K., Mensah, E., Wandeler, G., Riebensahm, C., Chihota, B., Samala, N. R., et al. (2024) · AIDS · doi:10.1097/qad.0000000000004012 · Cited by 4
Machine learning approaches for predicting frailty base on multimorbidities in US adults using NHANES data (1999–2018)
Li, T., Li, X., Haoran, X. U., Wang, Y., Ren, J., Jing, S., Jin, Z., Chen, G., Zhai, Y., Wu, Z., et al. (2024) · Computer Methods and Programs in Biomedicine Update · doi:10.1016/j.cmpbup.2024.100164 · Cited by 4
A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population
Sato, S., Iino, C., Sasada, T., Furusawa, K., Yoshida, K., Sawada, K., Mikami, T., Fukuda, S., Nakaji, S., & Sakuraba, H. (2025) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.24-00365 · Cited by 4
Relationship between serum uric acid levels and metabolism associated fatty liver disease in postmenopausal women based on NHANES 2017–2020
Zhou, X., Yue, Z., He, S., Yuan, F., He, X., Wang, J., Wang, R., Luo, Y., & Yi, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-93738-3 · Cited by 4
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD
Yang, T., Yang, B., Yin, J., Hou, C., & Wang, Q. (2025) · Biomedicines · doi:10.3390/biomedicines13040842 · Cited by 7
Trends and Disparities in Cardiovascular Disease in US Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease
Zhang, Y., Zhang, X., Huang, C., & Zhu, L. (2025) · Biomedicines · doi:10.3390/biomedicines13040956 · Cited by 5
HIV-Associated NAFLD: Disease Burden and Management
Kaplan, A. J., & Price, J. C. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00501-0 · Cited by 4
Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
Macı́as, J., Membrives, P. P., Sosa‐Moreno, F., Rincón, P., Martínez-Baena, D., Fernández‐Fuertes, M., Lorente-Herce, J. M., Martinez, R. C., Jiménez-Riera, G., Corma‐Gómez, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-25931-7 · Cited by 4
The Past, Present, and Future of Noninvasive Test in Chronic Liver Diseases
Chee, D., Ng, C. H., Chan, K. E., Huang, D. Q., Teng, M. L. P., & Muthiah, M. D. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.12.001 · Cited by 4
Prevalence and Determinants of Undiagnosed Liver Steatosis and Fibrosis in a Nationally Representative Sample of US Adults
Bhattacharyya, M., Nickols‐Richardson, S. M., Miller, A. L., Bhattacharyya, R., Frankhauser, F., & Miller, L. E. (2023) · Cureus · doi:10.7759/cureus.46783 · Cited by 4

Authors: Karlas, T., Petroff, D., Sasso, M., Fan, J.-G., Mi, Y.-Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K.-H., Cardoso, A. C., Ferraioli, G., Chan, W.-K., Wong, V. W.-S., Myers, R. P., Chayama, K., Friedrich-Rust, M., Beaugrand, M., Shen, F., Hiriart, J.-B., Sarin, S. K., Badea, R., Jung, K. S., Marcellin, P., Filice, C., Mahadeva, S., Wong, G. L.-H., Crotty, P., Masaki, K., Bojunga, J., Bedossa, P., Keim, V., & Wiegand, J.
Affiliations: University Hospital Leipzig (DE)
IFB Adiposity Diseases (DE)
Echosens (France) (FR)
Shanghai Jiao Tong University (CN)
Institute of Liver and Biliary Sciences (IN)
Yonsei University (KR)
Inserm (FR)
University of Pavia (IT)
University of Malaya (MY)
Chinese University of Hong Kong (HK)
University of Calgary (CA)
Hiroshima University Hospital (JP)
Hôpital Jean-Verdier (FR)
Centre Hospitalier Universitaire de Bordeaux (FR)
Iuliu Hațieganu University of Medicine and Pharmacy (RO)
University Hospital Frankfurt (DE)
Corresponding author: Wiegand, Johannes
ORCID: Karlas, Thomas
Petroff, David
Sasso, Magali
Fan, Jian-Gao
Kumar, Manoj
Han, Kwang-Hyub
Cardoso, Ana C.
Ferraioli, Giovanna
Chan, Wah-Kheong
Wong, Vincent Wai-Sun
Chayama, Kazuaki
Shen, Feng
Hiriart, Jean-Baptiste
Sarin, Shiv K.
Badea, Radu
Marcellin, Patrick
Mahadeva, Sanjiv
Wong, Grace Lai-Hung
Crotty, Pam
Bojunga, Joerg
Wiegand, Johannes
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2017-05
Volume: 66
Issue: 5
Pages: 1022-1030
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2016.12.022
OpenAlex: W2564467149
Cited by: 1,275
References: 65
Citations by year: 2026: 164 · 2025: 185 · 2024: 180 · 2023: 139 · 2022: 161 · 2021: 150 · 2020: 117 · 2019: 77 · 2018: 67 · 2017: 31
FWCI: 7.94
Type: journal article
Language: en
Open access: green
www.sciencedirect.com
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Ultrasound Imaging and Elastography
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Ultrasound in Clinical Applications
Keywords: controlled attenuation parameter, hepatic steatosis, vibration-controlled transient elastography, FibroScan, chronic liver disease, diabetes mellitus, body mass index, liver ultrasound, receiver operating characteristic
MeSH terms: Adult, Fatty Liver, Female, Humans, Male, Middle Aged, ROC Curve, Ultrasonography, Meta-Analysis as Topic, Body Mass Index, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks